Literature DB >> 21972967

A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.

Helene Köster1, Tobias Craan, Sascha Brass, Christian Herhaus, Matthias Zentgraf, Lars Neumann, Andreas Heine, Gerhard Klebe.   

Abstract

Druglike molecules are defined by Lipinski's rule of 5, to characterize fragment thresholds, they have been reduced from 5 to 3 (Astex's rule of 3). They are applied to assemble fragment libraries, and providers use them to select fragments for commercial offer. We question whether these rules are too stringent to compose fragment libraries with candidates exhibiting sufficient room for chemical subsequent growing and merging modifications as appropriate functional groups for chemical transformations are required. Usually these groups exhibit properties as hydrogen bond donors/acceptors and provide entry points for optimization chemistry. We therefore designed a fragment library (364 entries) without strictly applying the rule of 3. For initial screening for endothiapepsin binding, we performed a biochemical cleavage assay of a fluorogenic substrate at 1 mM. "Hits" were defined to inhibit the enzyme by at least 40%. Fifty-five hits were suggested and subsequently soaked into endothiapepsin crystals. Eleven crystal structures could be determined covering fragments with diverse binding modes: (i) direct binding to the catalytic dyad aspartates, (ii) water-mediated binding to the aspartates, (iii) no direct interaction with the dyad. They occupy different specificity pockets. Only 4 of the 11 fragments are consistent with the rule of 3. Restriction to this rule would have limited the fragment hits to a strongly reduced variety of chemotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972967     DOI: 10.1021/jm200642w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

1.  The 'rule of three' for fragment-based drug discovery: where are we now?

Authors:  Harren Jhoti; Glyn Williams; David C Rees; Christopher W Murray
Journal:  Nat Rev Drug Discov       Date:  2013-07-12       Impact factor: 84.694

2.  Natural-product-derived fragments for fragment-based ligand discovery.

Authors:  Björn Over; Stefan Wetzel; Christian Grütter; Yasushi Nakai; Steffen Renner; Daniel Rauh; Herbert Waldmann
Journal:  Nat Chem       Date:  2012-12-02       Impact factor: 24.427

3.  Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library.

Authors:  Franziska U Huschmann; Janina Linnik; Karine Sparta; Monika Ühlein; Xiaojie Wang; Alexander Metz; Johannes Schiebel; Andreas Heine; Gerhard Klebe; Manfred S Weiss; Uwe Mueller
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-04-22       Impact factor: 1.056

4.  Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.

Authors:  Florian C Schrader; Serghei Glinca; Julia M Sattler; Hans-Martin Dahse; Gustavo A Afanador; Sean T Prigge; Michael Lanzer; Ann-Kristin Mueller; Gerhard Klebe; Martin Schlitzer
Journal:  ChemMedChem       Date:  2013-01-22       Impact factor: 3.466

5.  Considerations of Protein Subpockets in Fragment-Based Drug Design.

Authors:  Matthew Bartolowits; V Jo Davisson
Journal:  Chem Biol Drug Des       Date:  2015-08-31       Impact factor: 2.817

6.  Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1α protein-protein interface.

Authors:  Inge Van Molle; Andreas Thomann; Dennis L Buckley; Ernest C So; Steffen Lang; Craig M Crews; Alessio Ciulli
Journal:  Chem Biol       Date:  2012-10-26

Review 7.  Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.

Authors:  Yuemin Bian; Xiang-Qun Sean Xie
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

8.  Synthesis and in Vitro Evaluation of Novel 5-Nitroindole Derivatives as c-Myc G-Quadruplex Binders with Anticancer Activity.

Authors:  Vijaykumar D Nimbarte; Julia Wirmer-Bartoschek; Santosh L Gande; Islam Alshamleh; Marcel Seibert; Hamid Reza Nasiri; Frank Schnütgen; Hubert Serve; Harald Schwalbe
Journal:  ChemMedChem       Date:  2021-03-22       Impact factor: 3.466

9.  Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2.

Authors:  M Cris Silva-Santisteban; Isaac M Westwood; Kathy Boxall; Nathan Brown; Sam Peacock; Craig McAndrew; Elaine Barrie; Meirion Richards; Amin Mirza; Antony W Oliver; Rosemary Burke; Swen Hoelder; Keith Jones; G Wynne Aherne; Julian Blagg; Ian Collins; Michelle D Garrett; Rob L M van Montfort
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.

Authors:  Alwin M Hartman; Milon Mondal; Nedyalka Radeva; Gerhard Klebe; Anna K H Hirsch
Journal:  Int J Mol Sci       Date:  2015-08-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.